Characterization of a cDNA encoding murine coagulation factor VII

Thrombosis and Haemostasis

Volumn 75, Issue 3, 1996, Pages 481-487

  Idusogie, Esohe ^a   Rosen, Elliot ^a,b   Geng, Jie Ping ^a   Carmeliet, Peter ^b   Collen, Desiré ^b   Castellino, Francis J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; COMPLEMENTARY DNA; MESSENGER RNA; NUCLEOTIDE; POLYADENYLATED RNA;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CATTLE; CODON; CONTROLLED STUDY; DNA LIBRARY; DNA SEQUENCE; DOG; LIVER; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DOMAIN; RABBIT; RHESUS MONKEY; RNA TRANSLATION; STOP CODON;

EID: 0029914396     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650301     Document Type: Article

References (58)

1. Kisiel W, Davie E. Isolation and characterization of bovine factor VII. Biochemistry 1975; 14: 4928-34.
2. Hagen FS, Gray CL, O'Hara P, Grant FJ, Saari GC, Woodbury RG, Hart CE, Insley M, Kisiel W, Kurachi K, Davie EW. Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci USA 1986; 83: 2412-6.
3. Pedersen AH, Nordfang O, Norris F, Wiberg FC, Christensen PM, Moeller KB, Midahl-Pedersen J, Beck TC, Norris K, Hedner U, Kisiel W. Recombinant human extrinsic pathway inhibitor. Production, isolation and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions. J Biol Chem 1990; 265: 16786-93.
4. Komiyama Y, Pedersen AH, Kisiel W. Proteolytic activation of human factors IX and X by recombinant human factor VIIa: Effects of calcium, phospholipid and tissue factor. Biochemistry 1990; 29: 9418-25.
5. tenCate H, Bauer KA, Levi M, Edgington TS, Sublett RD, Barzegar S, Kass BL, Rosenberg RD. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest 1993; 92: 1207-12.
6. Teglt DSC, Macik BG, McCord DM, Monroe D, Roberts HR. Mechanism by which recombinant factor VIIa shortens the aPTT: Activation of factor X in the absence of tissue factor. Thromb Res 1989; 56: 603-9.
7. Seligsohn U, Osterud B, Brown SF, Griffin JH, Rapaport SI. Activation of human factor VII in plasma and in purified systems. Roles of activated factor IX, kallikrein, and activated factor XII. J Clin Invest 1979; 64: 1056-65.
8. Broze GJ, Majerus PJ. Human factor VII. Methods Enzymol 1981; 80: 228-37.
9. Pedersen AH, Lund-Hansen D, Bisgaard-Frantzen H, Olsen F, Petersen LC. Autoactivation of human recombinant factor VII. Biochemistry 1989; 28: 9331-6.
10. Nakagaki T, Foster DC, Berkner KL, Kisiel W. Initiation of the extrinsic pathway of blood coagulation: Evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry 1991; 30: 10819-24.
11. Neuenschwander PF, Fiore MM, Morrissey JH. Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a 2-dimensional enzyme kinetic mechanism. J Biol Chem 1993; 268: 21489-92.
12. Thim L, Bjoern S, Christensen M, Nicolaisen EM, Lund-Hansen T, Pedersen AH, Hedner U. Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells. Biochemistry 1988; 27: 7785-93.
13. McMullen BA, Fujikawa K, Kisiel W. The occurrence of β-hydroxyaspartic acid in the vitamin K-dependent blood coagulation zymogens. Biochem Biophys Res Comm 1983; 115: 8-14.
14. 2-glc) O-glycosidically linked to a serine residue in the first epidermal growth factor-like domain of human factors VII and IX and protein Z and bovine protein Z J Biol Chem 1989; 264: 20320-5.
15. Bjoern S, Foster DC, Thim L, Wiberg FC, Christensen M, Komiyama Y, Pedersen AH, Kisiel W. Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine. J Biol Chem 1991; 266. 11051-7.
16. Foster DC, Yoshitake S, Davie EW. The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA 1985; 82: 4673-7.
17. Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry 1985; 24: 3736-50.
18. Leytus SP, Foster DC, Kurachi K, Davie EW. Gene for human factor X: A blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. Biochemistry 1986, 25: 5098-102.
19. O'Hara PJ, Grant FJ, Haldeman BA, Gray CL, Insley MY, Hagen FS, Murray MJ. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci USA 1987; 84: 5158-62.
20. Matsushita T, Kojima T, Emi N, Takahashi I, Satio H. Impaired human tissue factor-mediated activity in blood clotting factor VII (Nagoya) (ARG(304)->trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor. J Biol Chem 1994; 269: 7355-63.
21. Ohiwa M, Hayashi T, Wada H, Minamikawa K, Shirakawa S, Suzuki K. Factor VII MIE. Homozygous asymptomatic type-I deficiency caused by an amino acid substitution of His (CAC) for ARG(247)(CGC) in the catalytic domain. Thromb Haemost 1994; 71: 773-7.
22. Mariani G, Iacopino G, Pasqualilasagni R. Evidence that factor VII levels correlate strongly with fibrinopeptide A release. Evaluation by an ex vivo method. Int J Clin Lab Res 1992; 22: 111-4.
23. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-7.
24. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14: 54-9.
25. Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries SA. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991; 11: 540-6.
26. Lane A, Cruickshank JK, Mitchell J, Henderson A, Humphries S, Green F. Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heat disease. Atherosclerosis 1992; 94: 43-50.
27. Kario K, Matsuo T, Yamada T, Nakao K, Shimano C, Matsuo M. Factor VII hyperactivity in chronic dialysis patients. Thromb Res 1992; 67: 105-13.
28. Kario K, Matsuo T, Matsuo M, Koide M, Yamada T, Nakamura S, Sakata T, Kato H, Miyata T. Marked increase of activated factor VII in uremic patients. Thromb Haemost 1995; 73: 763-7.
29. Pearson WR, Lipman DJ. Improved tools for biological sequence comparison Proc Natl Acad Sci USA 1988; 85: 2444-8.
30. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215: 403-10.
31. 7D) of human activated protein C displays greatly reduced activity as an anticoagulant. Biochemistry 1990; 29: 10828-34.
32. Israel DI. A PCR-based method for high stringency screening of DNA libraries. Nucl Acids Res 1993; 21: 2627-31.
33. Menhart N, Sehl LC, Kelley RF, Castellino FJ. Construction, expression and purification of recombinant kringle 1 of human plasminogen and analysis of its interaction with ω-amino acids. Biochemistry 1991; 30: 1948-57.
34. De Serrano VS, Menhart N, Castellino FJ. The expression, purification and characterization of the recombinant kringle 1 domain from tissue-type plasminogen activator. Arch Biochem Biophys 1992; 294: 282-90.
35. De Serrano VS, Castellino FJ. The role of tryptophan-74 of the recombinant kringel 2 domain of tissue-type plasminogen activator in its ω-amino acid binding properties. Biochemistry 1992; 31: 3326-35.
36. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-7.
37. Staden E. A new computer method for the storage and manipulation of DNA gel reading data. Nucl Acids Res 1980; 8: 3673-94.
38. Takeya H, Kawabata S-i, Nakagawa K, Yamamichi Y, Miyata T, Iwanaga S, Takao T, Shimonishi Y. Bovine factor VII. Its purification and complete amino acid sequence. J Biol Chem 1988; 262: 14868-77.
39. Brothers AB, Clarke BJ, Sheffield WP, Blajchman MA. Complete nucleotide sequence of the cDNA encoding rabbit coagulation factor VII. Thromb Res 1993; 69: 231-8.
40. Murakawa M, Okamura T, Kamura T, Kuroiwa M, Harada M, Niho Y. Analysis of the partial nucleotide sequences and deduced primary structures of the protease domains of mammalian blood coagulation factors VII and X. Eur J Haematol 1994; 52: 162-8.
41. Huber P, Schmitz T, Griffin J, Jacobs M, Walsh C, Furie B, Furie BC. Identification of amino acids in the γ-carboxylation recognition site of the propeptide of prothrombin. J Biol Chem 1990; 265: 12467-73.
42. Zhang L, Castellino FJ. The binding energy of human coagulation protein C to acidic phospholipid vesicles contains a major contribution from leucine-5 in the gamma-carboxyglutamic acid domain. J Biol Chem 1994; 269: 3590-5.
43. 2+ ion and membrane binding structure of the gla-domain of Ca-prothrombin fragment 1. Biochemistry 1992; 31: 2554-66.
44. Zhang L, Jhingan A, Castellino FJ. Role of individual gamma-carboxyglulamic acid residues of activated human protein C in defining its in vitro anticoagulant activitiy. Blood 1992; 80: 942-52.
45. Zhang L, Castellino FJ. Role of the hexapeptide disulfide loop present in the γ-carboxyglutamic acid domain of protein C in its activation properties and in the in vitro anticoagulant activity of activated protein C. Biochemistry 1991; 30: 6696-704.
46. Christiansen WT, Geng J-P, Castellino FJ. Structure-function assessment of the role of the helical stack domain in the properties of human recombinant protein C and activated protein C. Biochemistry 1995; 34: 8082-90.
47. Colpitts TL, Castellino FJ. Calcium and phospholipid binding properties of synthetic gamma-carboxyglutamic acid-containing peptides with sequence counterparts in human protein C. Biochemistry 1994; 33: 3501-8.
48. Valcarce C, Holmgren A, Stenflo J. Calcium-dependent interaction between gamma-carboxyglutamic acid-containing and N-terminal epidermal growth factor-like modules in factor X. J Biol Chem 1994; 269: 26011-6.
49. Handford PA, Mayhew M, Baron M, Winship PR, Campbell ID, Brownlee GG. Key residues involved in calcium-binding motifs in EGF-like proteins. Nature 1991; 351: 164-7.
50. 2-terminal EGF-like domain in coagulation factor X. J Biol Chem 1992; 267: 19642-9.
51. 2+ binding of EGF-like domains. Protein Eng 1992; 5: 489-94.
52. Hughes PE, Handford PA, Austen DEG, Brownlee GG. Protein engineering of the hydrophobic domain of human factor IX. Protein Eng 1994; 7: 1121-7.
53. Sridhara S, Clarke BJ, Blajchman MA. Arginine 79 in the 1st epidermal growth factor domain of factor VII is essential for the interaction with tissue factor. Blood Coag Fibrinol 1993; 4: 505-6.
54. Takamiya O, Abe S, Yoshioka A, Nakajima K, McVey JH, Tuddenham EGD. Factor VIIShinjo: a dysfunctional factor VII variant homozygous for the substitution gln for arg at position 79. Haemostasia 1995; 25: 89-97.
55. Ruf W. Factor VIIa residue arg(290) is required for efficient activation of the macromolecular substrate factor X Biochemistry 1994; 33: 11631-6.
56. Bernardi F, Castaman G, Redaelli R, Pinotti M, Lunghi B, Rodeghiero F, Marchetti G. Topologically equivalent mutations causing dysfunctional coagulation factors VII ((294)Ala->Val) and X ((334)Ser->Pro). Hum Mol Genet 1994; 3: 1175-7
57. Bernardi F, Liney DL, Patracchini P, Gemmati D, Legnani C, Arcieri P, Pinotti M, Redaelli R, Ballerini G, Pemberton S, Wacey AI, Mariani G, Tuddenham EGD, Marchetti G. Molecular defects in CRM+ factor VII deficiencies. Modeling of missense mutations in the catalytic domain of fVII. Br J Haematol 1994; 86: 610-8.
58. Wildgoose P, Kazim AL, Kisiel W. The importance of residues 195-206 of human blood clotting factor VII in the interaction of factor VII with tissue factor. Proc Natl Acad Sci USA 1990; 87: 7290-4.